Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cells

Journal of the Society for Gynecologic Investigation

Volumn 10, Issue 2, 2003, Pages 82-93

  Xia, Yang ^a   Wen, Hong ^a   Bobst, Sol ^a   Day, Mary Clare ^a   Kellems, Rodney E ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

AT1 agonistic autoantibody (AT1 AA); Calcineurin NFAT; Hypercoagulation; Plasminogen activator inhibitor 1 (PAI 1); Preeclampsia; Trophoblast invasion

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; AUTOANTIBODY; CALCINEURIN; CYCLOSPORIN A; IMMUNOGLOBULIN G; LOSARTAN; MATERNAL ANTIBODY; MATRIGEL; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSCRIPTION FACTOR NFAT;

ANIMAL CELL; ARTICLE; ASSAY; CALCIUM SIGNALING; CELL IMMORTALIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG ACTIVITY; FEMALE; GENE EXPRESSION; HEART BEAT; HEART CELL CULTURE; HEART CONTRACTION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; NEWBORN; NONHUMAN; OUTCOMES RESEARCH; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TROPHOBLAST; UTERUS CONTRACTILITY; UTERUS CONTRACTION;

ANIMALS; AUTOANTIBODIES; CELL NUCLEUS; CELLS, CULTURED; CYCLOSPORINE; CYTOPLASM; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNE SERA; MOTHERS; MYOCYTES, CARDIAC; NFATC TRANSCRIPTION FACTORS; NUCLEAR PROTEINS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PRE-ECLAMPSIA; PREGNANCY; PROTEIN TRANSPORT; RATS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANGIOTENSIN; RECOMBINANT PROTEINS; REFERENCE VALUES; TRANSCRIPTION FACTORS; TROPHOBLASTS;

EID: 0037317090     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-5576(02)00259-9     Document Type: Article

References (36)

1. Saftlas A.F., Olson D.R., Franks A.L., Atrash H.K., Pokras R. Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986. Am J Obstet Gynecol. 163:1990;460-465.
2. Granger J.P., Alexander B.T., Bennett W.A., Khalil R.A. Pathophysiology of pregnancy-induced hypertension. Am J Hypertens. 14:(Suppl):2001;178S-185S.
3. Roberts J.M., Lain K.Y. Preterm birth and pre-eclampsia - bad news and good news. Lancet. 352:(Suppl 4):1998;SIV22.
4. Gerretsen G., Huisjes H.J., Elema J.D. Morphological changes of the spiral arteries in the placental bed in relation to pre-eclampsia and fetal growth retardation. Br J Obstet Gynaecol. 88:1981;876-881.
5. Granger J.P., Alexander B.T., Llinas M.T., Bennett W.A., Khalil R.A. Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction. Hypertension. 38:2001;718-722.
6. Khong T.Y., Pearce J.M., Robertson W.B. Acute atherosis in preeclampsia Maternal determinants and fetal outcome in the presence of the lesion. Am J Obstet Gynecol. 157:1987;360-363.
7. Fisher S.J., Leitch M.S., Kantor M.S., Basbaum C.B., Kramer R.H. Degradation of extracellular matrix by the trophoblastic cells of first-trimester human placentas. J Cell Biochem. 27:1985;31-41.
8. Hofmann G.E., Glatstein I., Schatz F., Heller D., Deligdisch L. Immunohistochemical localization of urokinase-type plasminogen activator and the plasminogen activator inhibitors 1 and 2 in early human implantation sites. Am J Obstet Gynecol. 170:1994;671-676.
9. Queenan J.T. Jr, Kao L.C., Arboleda C.E., et al. Regulation of urokinase-type plasminogen activator production by cultured human cytotrophoblasts. J Biol Chem. 262:1987;10903-10906.
10. Wun T.C., Reich E. An inhibitor of plasminogen activation from human placenta. Purification and characterization. J Biol Chem. 262:1987;3646-3653.
11. Sappino A.P., Huarte J., Belin D., Vassalli J.D. Plasminogen activators in tissue remodeling and invasion mRNA localization in mouse ovaries and implanting embryos. J Cell Biol. 109:1989;2471-2479.
12. Feinberg R.F., Kao L.C., Haimowitz J.E., et al. Plasminogen activator inhibitor types 1 and 2 in human trophoblasts. PAI-1 is an immunocytochemical marker of invading trophoblasts. Lab Invest. 61:1989;20-26.
13. Blasi F., Vassalli J.D., Dano K. Urokinase-type plasminogen activator Proenzyme, receptor, and inhibitors. J Cell Biol. 104:1987;801-804.
14. Carmeliet P., Moons L., Herbert J.M., et al. Urokinase but not tissue plasminogen activator mediates arterial neointima formation in mice. Circ Res. 81:1997;829-839.
15. Ellis V., Behrendt N., Dano K. Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor. J Biol Chem. 266:1991;12752-12758.
16. Saksela O., Rifkin D.B. Cell-associated plasminogen activation Regulation and physiological functions. Annu Rev Cell Biol. 4:1988;93-126.
17. Lala P.K., Graham C.H. Mechanisms of trophoblast invasiveness and their control The role of proteases and protease inhibitors. Cancer Metastasis Rev. 9:1990;369-379.
18. Lala P.K., Graham C.G. TGFB-responsive human trophoblast-derived cell lines. Placenta. 22:2001;889-890.
19. Xia Y., Wen H.Y., Kellems R.E. Angiotensin II inhibits human trophoblast invasiveness through AT-1 receptor activation. J Biol Chem. 277:2002;24601-24608.
20. Wallukat G., Homuth V., Fischer T., et al. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest. 103:1999;945-952.
21. Xia Y., McMillin J.B., Lewis A., et al. Electrical stimulation of neonatal cardiac myocytes activates the NFAT3 and GATA4 pathways and up-regulates the adenylosuccinate synthetase 1 gene. J Biol Chem. 275:2000;1855-1863.
22. Graham C.H., Hawley T.S., Hawley R.G., et al. Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Exp Cell Res. 206:1993;204-211.
23. McMahon G.A., Petitclerc E., Stefansson S., et al. Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis. J Biol Chem. 276:2001;33964-33968.
24. Ahn J.D., Morishita R., Kaneda Y., et al. Transcription factor decoy for activator protein-1 (AP-1) inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor (PAI-1) gene expression in cultured human vascular smooth muscle cells. Diabetologia. 44:2001;713-720.
25. Lala PK, Hamilton GS. Growth factors, proteases and protease inhibitors in the maternal-fetal dialogue. Placenta 1996;17:545-545.
26. de Boer K., Lecander I., ten Cate J.W., Borm J.J., Treffers P.E. Placental-type plasminogen activator inhibitor in preeclampsia. Am J Obstet Gynecol. 158:1988;518-522.
27. Estelles A., Gilabert J., Grancha S., et al. Abnormal expression of type 1 plasminogen activator inhibitor and tissue factor in severe preeclampsia. Thromb Haemost. 79:1998;500-508.
28. Nakamura S., Nakamura I., Ma L., Vaughan D.E., Fogo A.B. Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo. Kidney Int. 58:2000;251-259.
29. Fogo A.B. The role of angiotensin II and plasminogen activator inhibitor-1 in progressive glomerulosclerosis. Am J Kidney Dis. 35:2000;179-188.
30. Chen H.C., Bouchie J.L., Perez A.S., et al. Role of the angiotensin AT(1) receptor in rat aortic and cardiac PAI-1 gene expression. Arterioscler Thromb Vasc Biol. 20:2000;2297-2302.
31. Feener E.P., Northrup J.M., Aiello L.P., King G.L. Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells. J Clin Invest. 95:1995;1353-1362.
32. Rossi G.P., Sacchetto A., Cesari M., Pessina A.C. Interactions between endothelin-1 and the renin-angiotensin-aldosterone system. Cardiovasc Res. 43:1999;300-307.
33. de Jong C.L., Dekker G.A., Sibai B.M. The renin-angiotensin-aldosterone system in preeclampsia. A review. Clin Perinatol. 18:1991;683-711.
34. Gant N.F., Daley G.L., Chand S., Whalley P.J., MacDonald P.C. A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest. 52:1973;2682-2689.
35. Roberts J.M., Redman C.W. Pre-eclampsia More than pregnancy-induced hypertension. Lancet. 341:1993;1447-1451.
36. Dechend R., Homuth V., Wallukat G., et al. AT1 receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation. 101:2000;2382-2387.